Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 3 Rates of recurrent myocardial infarction and cardiovascular death among acute coronary syndrome patients treated with statin therapy according to achieved levels of low density lipoprotein (LDL)-cholesterol and high sensitivity C-reactive protein (CRP) in the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22 trial. Adapted, with permission, from Ridker et al. (40).
|
